NVOS
Novo Integrated Sciences, Inc.
Price Chart
Latest Quote
$0.00
| Previous Close | $0.00 |
| Open | $0.01 |
| Day High | $0.01 |
| Day Low | $0.01 |
| Volume | 1,507 |
Stock Information
| Shares Outstanding | 19.73M |
| Total Debt | $5.98M |
| Cash Equivalents | $845K |
| Revenue | $13.29M |
| Net Income | $-16.17M |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Market Cap | $14K |
| EPS (TTM) | $-1.33 |
| Exchange | PNK |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $4.87M |
| Sales | $13.29M |
| Income | $-16.17M |
| Book/sh | $0.78 |
| Cash/sh | $0.04 |
| Employees | 115 |
Financial Ratios
| Quick Ratio | 0.19 |
| Current Ratio | 0.37 |
| Debt/Eq | 40.92 |
Returns & Margins
| ROA | -15.35% |
| ROE | -82.47% |
| Gross Margin | 43.20% |
| Operating Margin | -30.39% |
| Profit Margin | -121.61% |
Ownership
| Insider Ownership | 6.59% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 0.00 |
| P/B | 0.00 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.01 |
| SMA50 | $0.01 |
| SMA200 | $0.00 |
| RSI | 7.11 |
| ATR | 0.0026 |
| Shares Float | 18.43M |
| Short Float | 1.45% |
| Short Ratio | 1.13 |
| Volatility | 5.99 |
| Rel Volume | 0.23 |
Performance History
| Week | -92.22% |
| Month | -77.42% |
| Quarter | +16.67% |
| 6 Months | -66.67% |
| YTD | -74.07% |
| Year | -44.00% |
| 3 Years | -99.95% |
| 5 Years | -100.00% |
| 10 Years | -100.00% |
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-19 | $0.00 | 1,507 |
| 2026-06-18 | $0.00 | 0 |
| 2026-06-17 | $0.00 | 26,025 |
| 2026-06-16 | $0.00 | 5,006 |
| 2026-06-15 | $0.00 | 51,180 |
| 2026-06-12 | $0.01 | 0 |
| 2026-06-11 | $0.01 | 0 |
| 2026-06-10 | $0.01 | 0 |
| 2026-06-09 | $0.01 | 0 |
| 2026-06-08 | $0.01 | 0 |
| 2026-06-05 | $0.01 | 10,906 |
| 2026-06-04 | $0.02 | 0 |
| 2026-06-03 | $0.02 | 0 |
| 2026-06-02 | $0.02 | 0 |
| 2026-06-01 | $0.02 | 22,131 |
| 2026-05-29 | $0.02 | 0 |
| 2026-05-28 | $0.02 | 4,016 |
| 2026-05-27 | $0.02 | 5,025 |
| 2026-05-26 | $0.00 | 4,370 |
| 2026-05-22 | $0.00 | 3,176 |
| 2026-05-21 | $0.00 | 254 |
| 2026-05-20 | $0.00 | 1,714 |
| 2026-05-19 | $0.00 | 19,220 |
About Novo Integrated Sciences, Inc.
Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary care and related wellness products and services in Canada. It operates in two segments, Healthcare Services and Product Sales. The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, concussion management and baseline testing, trauma sensitive yoga and meditation for concussion-acquired brain injury and occupational stress-PTSD, women's pelvic health programs, sports medicine therapy, assistive devices, dietitian, holistic nutrition, fall prevention education, sports team conditioning programs, including event and game coverage, and private personal training services through clinics. It also provides assessment, diagnosis, treatment, pain management, rehabilitation, education, and prevention of various orthopedic, musculoskeletal, sports injury, and neurological conditions across pediatric, adult, and geriatric populations. In addition, the company offers eldercare physiotherapy services through long-term care homes, retirement homes, community-based home care physiotherapy, community-based group exercise classes and fall prevention programs, and community-based outpatient clinics; and elderly occupational therapy services for retirement homes and community, and long-term care sectors. Further, it provides medical technology platforms, such as Novo Connect, telemedicine/telehealth, and remote patient monitoring; and develops and distributes personalized health and wellness product solutions. The company was formerly known as Turbine Truck Engines, Inc. and changed its name to Nova Integrated Sciences, Inc. in July 2017. The company is headquartered in Bellevue, Washington.
đ° Latest News
Income Statement (Annual)
| Metric | 2023-08-31 | 2022-08-31 | 2021-08-31 |
|---|---|---|---|
| Revenue | |||
| Reconciled Cost Of Revenue | $7,619,304 | $6,938,699 | $5,482,257 |
| Cost Of Revenue | $7,619,304 | $6,938,699 | $5,482,257 |
| Total Revenue | $12,572,019 | $11,737,937 | $9,305,255 |
| Operating Revenue | $12,572,019 | $11,737,937 | $9,305,255 |
| Expenses | |||
| Interest Expense | $5,117,692 | $7,568,248 | $165,003 |
| Total Expenses | $21,125,181 | $21,324,040 | $13,579,423 |
| Other Income Expense | $392,383 | $-16,082,217 | $-77,451 |
| Other Non Operating Income Expenses | $607,589 | - | $21,900 |
| Net Non Operating Interest Income Expense | $-5,108,665 | $-7,399,160 | $-119,316 |
| Interest Expense Non Operating | $5,117,692 | $7,568,248 | $165,003 |
| Operating Expense | $13,505,877 | $14,385,341 | $8,097,166 |
| Selling And Marketing Expense | $15,149 | $20,702 | $7,525 |
| General And Administrative Expense | $13,490,728 | $14,364,639 | $8,089,641 |
| Income & Earnings | |||
| Net Income From Continuing Operation Net Minority Interest | $-13,214,552 | $-32,849,215 | $-4,462,147 |
| Net Interest Income | $-5,108,665 | $-7,399,160 | $-119,316 |
| Interest Income | $9,027 | $169,088 | $45,687 |
| Normalized Income | $-12,999,346 | $-16,766,998 | $-4,362,796 |
| Net Income From Continuing And Discontinued Operation | $-13,214,552 | $-32,849,215 | $-4,462,147 |
| Total Operating Income As Reported | $-8,553,162 | $-25,026,677 | $-4,373,519 |
| Net Income Common Stockholders | $-13,214,552 | $-32,849,215 | $-4,462,147 |
| Net Income | $-13,214,552 | $-32,849,215 | $-4,462,147 |
| Net Income Including Noncontrolling Interests | $-13,269,444 | $-33,045,178 | $-4,470,935 |
| Net Income Continuous Operations | $-13,269,444 | $-33,045,178 | $-4,470,935 |
| Pretax Income | $-13,269,444 | $-33,067,480 | $-4,470,935 |
| Special Income Charges | $0 | $-15,440,574 | $-99,351 |
| Interest Income Non Operating | $9,027 | $169,088 | $45,687 |
| Operating Income | $-8,553,162 | $-9,586,103 | $-4,274,168 |
| Gross Profit | $4,952,715 | $4,799,238 | $3,822,998 |
| Per Share | |||
| Diluted EPS | $-1.30 | $-11.30 | $-1.80 |
| Basic EPS | $-1.30 | $-11.30 | $-1.80 |
| Other | |||
| Tax Effect Of Unusual Items | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-5,633,792 | $-6,397,762 | $-2,482,459 |
| Total Unusual Items | $-215,206 | $-16,082,217 | $-99,351 |
| Total Unusual Items Excluding Goodwill | $-215,206 | $-16,082,217 | $-99,351 |
| Reconciled Depreciation | $2,302,754 | $3,019,253 | $1,724,122 |
| EBITDA (Bullshit earnings) | $-5,848,998 | $-22,479,979 | $-2,581,810 |
| EBIT | $-8,151,752 | $-25,499,232 | $-4,305,932 |
| Diluted Average Shares | $10,165,548 | $2,912,262 | $2,477,445 |
| Basic Average Shares | $10,165,548 | $2,912,262 | $2,477,445 |
| Diluted NI Availto Com Stockholders | $-13,214,552 | $-32,849,215 | $-4,462,147 |
| Minority Interests | $54,892 | $195,963 | $8,788 |
| Tax Provision | $0 | $-22,302 | $0 |
| Write Off | $0 | $14,083,531 | $99,351 |
| Impairment Of Capital Assets | $0 | $1,357,043 | $99,351 |
| Gain On Sale Of Security | $-215,206 | $-641,643 | - |
| Selling General And Administration | $13,505,877 | $14,385,341 | $8,097,166 |
| Other Gand A | $13,490,728 | $14,364,639 | $8,089,641 |
Balance Sheet (Annual)
| Metric | 2023-08-31 | 2022-08-31 | 2021-08-31 |
|---|---|---|---|
| Assets | |||
| Net Tangible Assets | $1,014,923 | $-4,361,304 | $2,346,069 |
| Total Assets | $35,563,047 | $40,872,840 | $61,958,281 |
| Total Non Current Assets | $31,174,958 | $35,141,045 | $50,824,772 |
| Goodwill And Other Intangible Assets | $23,801,022 | $26,666,463 | $41,518,347 |
| Other Intangible Assets | $16,218,539 | $18,840,619 | $32,029,499 |
| Current Assets | $4,388,089 | $5,731,795 | $11,133,509 |
| Other Current Assets | $346,171 | $571,335 | $218,376 |
| Prepaid Assets | $1,051,584 | $1,085,335 | $218,376 |
| Inventory | $1,106,983 | $879,033 | $339,385 |
| Receivables | $1,467,028 | $1,017,405 | $2,282,586 |
| Receivables Adjustments Allowances | $-864,215 | $-992,329 | $-1,097,628 |
| Other Receivables | $108,000 | $180,259 | $968,715 |
| Accounts Receivable | $2,223,243 | $1,829,475 | $2,411,499 |
| Cash Cash Equivalents And Short Term Investments | $416,323 | $2,178,687 | $8,293,162 |
| Cash And Cash Equivalents | $416,323 | $2,178,687 | $8,293,162 |
| Non Current Accounts Receivable | - | - | $692,738 |
| Debt | |||
| Net Debt | $1,934,613 | $8,028,677 | $2,787,216 |
| Total Debt | $4,471,649 | $12,995,747 | $13,708,381 |
| Long Term Debt And Capital Lease Obligation | $1,758,615 | $3,305,115 | $8,189,831 |
| Long Term Debt | $65,038 | $1,107,710 | $6,115,809 |
| Current Debt And Capital Lease Obligation | $2,713,034 | $9,690,632 | $5,518,550 |
| Current Debt | $2,285,898 | $9,099,654 | $4,964,569 |
| Other Current Borrowings | $2,285,898 | $9,099,654 | $4,964,569 |
| Liabilities | |||
| Total Liabilities Net Minority Interest | $11,063,972 | $18,825,269 | $18,154,126 |
| Total Non Current Liabilities Net Minority Interest | $3,159,114 | $4,750,563 | $9,690,203 |
| Non Current Deferred Liabilities | $1,400,499 | $1,445,448 | $1,500,372 |
| Non Current Deferred Taxes Liabilities | $1,400,499 | $1,445,448 | $1,500,372 |
| Current Liabilities | $7,904,858 | $14,074,706 | $8,463,923 |
| Other Current Liabilities | $61,767 | $534,595 | - |
| Current Deferred Liabilities | $35,434 | $36,887 | $38,631 |
| Payables And Accrued Expenses | $5,094,623 | $3,812,592 | $2,906,742 |
| Interest Payable | $382,666 | $454,189 | $366,280 |
| Payables | $3,513,842 | $2,279,165 | $1,449,784 |
| Accounts Payable | $3,513,842 | $1,800,268 | $1,449,784 |
| Equity | |||
| Common Stock Equity | $24,815,945 | $22,305,159 | $43,864,416 |
| Total Equity Gross Minority Interest | $24,499,075 | $22,047,571 | $43,804,155 |
| Stockholders Equity | $24,815,945 | $22,305,159 | $43,864,416 |
| Other Equity Interest | $1,217,293 | $9,474,807 | $9,236,607 |
| Gains Losses Not Affecting Retained Earnings | $-357,383 | $560,836 | $991,077 |
| Other Equity Adjustments | $-357,383 | $560,836 | $991,077 |
| Retained Earnings | $-67,033,041 | $-53,818,489 | $-20,969,274 |
| Other | |||
| Treasury Shares Number | $0 | - | - |
| Ordinary Shares Number | $16,811,879 | $3,118,060 | $2,661,014 |
| Share Issued | $16,811,879 | $3,118,060 | $2,661,014 |
| Tangible Book Value | $1,014,923 | $-4,361,304 | $2,346,069 |
| Invested Capital | $27,166,881 | $32,512,523 | $54,944,794 |
| Working Capital | $-3,516,769 | $-8,342,911 | $2,669,586 |
| Capital Lease Obligations | $2,120,713 | $2,788,383 | $2,628,003 |
| Total Capitalization | $24,880,983 | $23,412,869 | $49,980,225 |
| Minority Interest | $-316,870 | $-257,588 | $-60,261 |
| Additional Paid In Capital | $90,973,316 | $66,084,887 | $54,579,396 |
| Capital Stock | $15,760 | $3,118 | $26,610 |
| Common Stock | $15,760 | $3,118 | $26,610 |
| Preferred Stock | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $1,693,577 | $2,197,405 | $2,074,022 |
| Current Deferred Revenue | $35,434 | $36,887 | $38,631 |
| Current Capital Lease Obligation | $427,136 | $590,978 | $553,981 |
| Current Accrued Expenses | $1,580,781 | $1,533,427 | $1,456,958 |
| Goodwill | $7,582,483 | $7,825,844 | $9,488,848 |
| Net PPE | $7,373,936 | $8,474,582 | $8,613,687 |
| Accumulated Depreciation | $-1,253,209 | $-1,004,732 | $-646,442 |
| Gross PPE | $8,627,145 | $9,479,314 | $9,260,129 |
| Leases | $841,371 | $868,375 | $691,318 |
| Other Properties | $3,900,579 | $4,601,573 | $4,418,933 |
| Machinery Furniture Equipment | $116,295 | $119,503 | $112,208 |
| Buildings And Improvements | $3,325,500 | $3,432,232 | $3,562,650 |
| Land And Improvements | $443,400 | $457,631 | $475,020 |
| Properties | $0 | $0 | $0 |
| Inventories Adjustments Allowances | $0 | $-1,027,670 | $-1,066,721 |
| Finished Goods | $636,896 | $507,416 | $243,912 |
| Work In Process | $81,696 | $139,333 | $144,628 |
| Raw Materials | $388,391 | $1,259,954 | $1,017,566 |
| Dueto Related Parties Current | - | $478,897 | - |
Cash Flow Statement (Annual)
| Metric | 2023-08-31 | 2022-08-31 | 2021-08-31 |
|---|---|---|---|
| Free Cash Flow | |||
| Free Cash Flow | $-2,292,539 | $-6,074,313 | $-1,280,751 |
| Operating Activities | |||
| Operating Cash Flow | $-2,243,315 | $-5,884,145 | $-1,024,802 |
| Cash Flow From Continuing Operating Activities | $-2,243,310 | $-5,884,145 | $-1,024,802 |
| Operating Gains Losses | $215,206 | $641,643 | $133,596 |
| Investing Activities | |||
| Capital Expenditure | $-49,224 | $-190,168 | $-255,949 |
| Investing Cash Flow | $-49,224 | $163,459 | $2,999,122 |
| Cash Flow From Continuing Investing Activities | $-49,224 | $163,459 | $2,999,122 |
| Net Other Investing Changes | - | $296,138 | $-473,100 |
| Financing Activities | |||
| Issuance Of Capital Stock | $1,795,000 | $0 | $7,327,580 |
| Financing Cash Flow | $763,860 | $-427,117 | $4,316,862 |
| Cash Flow From Continuing Financing Activities | $763,860 | $-427,117 | $4,316,862 |
| Net Other Financing Charges | $7,206 | $16,600 | $-246,327 |
| Net Common Stock Issuance | $1,795,000 | $0 | $7,327,580 |
| Common Stock Issuance | $1,795,000 | $0 | $7,327,580 |
| Other | |||
| Repayment Of Debt | $-3,079,629 | $-15,713,717 | $-2,776,391 |
| Issuance Of Debt | $1,285,903 | $15,270,000 | $0 |
| Interest Paid Supplemental Data | $432,094 | $1,502,819 | $144,987 |
| Income Tax Paid Supplemental Data | $0 | $0 | $0 |
| End Cash Position | $416,323 | $2,178,687 | $8,293,162 |
| Beginning Cash Position | $2,178,687 | $8,293,162 | $2,067,718 |
| Effect Of Exchange Rate Changes | $-233,685 | $33,328 | $-65,738 |
| Changes In Cash | $-1,528,679 | $-6,147,803 | $6,291,182 |
| Proceeds From Stock Option Exercised | $532,600 | $0 | $12,000 |
| Net Issuance Payments Of Debt | $-1,570,946 | $-443,717 | $-2,776,391 |
| Net Short Term Debt Issuance | $-1,747,985 | $10,165,833 | $0 |
| Short Term Debt Payments | $-3,033,888 | $-5,104,167 | $0 |
| Short Term Debt Issuance | $1,285,903 | $15,270,000 | $0 |
| Net Long Term Debt Issuance | $177,039 | $-10,609,550 | $-2,776,391 |
| Long Term Debt Payments | $-45,741 | $-10,609,550 | $-2,776,391 |
| Net Business Purchase And Sale | $0 | $57,489 | $3,728,171 |
| Sale Of Business | $0 | $57,489 | $3,738,171 |
| Net PPE Purchase And Sale | $-49,224 | $-190,168 | $-255,949 |
| Purchase Of PPE | $-49,224 | $-190,168 | $-255,949 |
| Change In Working Capital | $460,679 | $-823,102 | $-29,100 |
| Change In Other Current Liabilities | $-762,852 | $-806,394 | $-618,645 |
| Change In Payables And Accrued Expense | $1,866,121 | $423,330 | $-323,247 |
| Change In Accrued Expense | $95,532 | $140,096 | $-278,019 |
| Change In Interest Payable | $-58,066 | $101,353 | $9,015 |
| Change In Payable | $1,770,589 | $283,234 | $-45,228 |
| Change In Account Payable | $1,770,589 | $283,234 | $-45,228 |
| Change In Prepaid Assets | $210,382 | $-369,647 | $-43,194 |
| Change In Inventory | $-255,781 | $-527,397 | $-147,814 |
| Change In Receivables | $-597,191 | $457,006 | $1,103,800 |
| Changes In Account Receivables | $-597,191 | $457,006 | $1,103,800 |
| Other Non Cash Items | $7,662,155 | $8,156,303 | $1,518,164 |
| Stock Based Compensation | $385,335 | $426,690 | $155,496 |
| Asset Impairment Charge | $0 | $15,740,246 | $99,351 |
| Depreciation Amortization Depletion | $2,302,754 | $3,019,253 | $1,724,122 |
| Depreciation And Amortization | $2,302,754 | $3,019,253 | $1,724,122 |
| Net Foreign Currency Exchange Gain Loss | $215,206 | $641,643 | $0 |
| Net Income From Continuing Operations | $-13,269,444 | $-33,045,178 | $-4,470,935 |
| Purchase Of Business | - | $0 | $-10,000 |
| Gain Loss On Investment Securities | - | $426,690 | $155,496 |